Smart-4-Fabry is the acronym of a H2020 funded Project
that stands for “Smart functional GLA-nanoformulation
for Fabry disease”. Smart-4-Fabry is a collaborative project
funded under the H2020 EU Research
and Innovation programme.
The project started on
the 1st January 2017 and will last four years.
“POST-WS RAREVIEW 2019, Innovation in lysosomal storage diseases” is the name of a hig...
All rare diseases need to enhance their awareness and social visibility. April is the mont...
“Personalized Medicines, Targeted Therapies, Precision Drug Delivery” 6th – ...